Russia is starting a new phase of clinical trials of the new Sputnik-5 vaccine against the emerging coronavirus, which will include more than 40,000 people in Moscow.
According to Reuters, the Russian Direct Investment Fund, which supports the vaccine, said that similar trials would be conducted in five other countries.
and the vaccine, approved by Russia, has received praise as safe and effective from authorities and Russian scientists following two months of small-scale human trials, yet to be announced Report their results.
(Amazon fun knowledge)
